Precise activation and tracking of cancer treatment with a new compound is possible
This class of inhibitors has shown therapeutic promise in several cancer types, including chronic lymphocytic leukemia and Burkitt lymphoma
United States Dylan Horton Kimberlee Speakman Wistar Institute University Of South Florida Microenvironment Metastasis Program
Source: innovationtoronto.com